Skip to content
Valve disease: TAVI and percutaneous repair
← All guides

Treatments

Valve disease: TAVI and percutaneous repair

Aortic stenosis and mitral regurgitation without opening the chest: days not weeks.

medviajes editorial teamUpdated: 1 min read

Calcified aortic stenosis and severe mitral regurgitation cause progressive breathlessness, syncope and congestive heart failure. For decades the only solution was open surgery with sternotomy, prohibitive for many older or frail patients.

Today transcatheter aortic valve implantation (TAVI) and percutaneous mitral repair allow catheter-guided valve treatment through the femoral artery, under conscious sedation in many centres. Hospital stay falls from weeks to days and surgical mortality in geriatric patients drops substantially.

Main risks are paravalvular leak, vascular access complications, conduction disorders that may require a pacemaker, and periprocedural stroke. The choice between TAVI and conventional surgery depends on age, surgical risk and valve anatomy, and should be made by a multidisciplinary valve team.

Device costs make these procedures expensive even in affordable destinations: the range is EUR 20,000 to 35,000, with ten to fourteen day stays. Singapore, Germany and the United States concentrate the most recognised interventional cardiologists and advanced hybrid theatres.

Medviajes organises information and questions for medical travel planning. Confirm credentials, availability, prices and follow-up directly with the healthcare provider; this guide does not mean Medviajes books or delivers those services.

Editorial standards ↗

General information, sources and clear limitations. No guide replaces a medical assessment.

No named medical review is recorded for this article.

This content is informational and does not replace advice from a healthcare professional. Always consult your doctor before making decisions about your health.

Related articles

Want a personalized plan? Talk to the AI assistant.

Plan with AI